MedPath

浙江亚峰药厂有限公司

Ownership
-
Established
2002-09-18
Employees
-
Market Cap
-
Website
https://www.yafeng.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Amoxicillin Granules

Product Name
阿莫西林颗粒
Approval Number
国药准字H33022119
Approval Date
Aug 7, 2024
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H33021420
Approval Date
Jul 24, 2024
NMPA

今幸牌车前草蒲公英片

Approval Number
国食健注G20210129
Approval Date
Nov 12, 2021
NMPA

Amoxicillin and Sulbactam Pivoxil Tablets

Product Name
悉林
Approval Number
国药准字H20061148
Approval Date
Aug 12, 2020
NMPA

Amoxicillin and Clavulanate Potassium Dispersible Tablets

Product Name
毕林
Approval Number
国药准字H20060652
Approval Date
Aug 12, 2020
NMPA

Pivoxil Sulbactam

Product Name
舒巴坦匹酯
Approval Number
国药准字H20060847
Approval Date
Jun 23, 2020
NMPA

Compound Sulfamethoxazole Granules

Product Name
复方磺胺甲噁唑颗粒
Approval Number
国药准字H33022118
Approval Date
May 7, 2020
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H33022441
Approval Date
Apr 26, 2020
NMPA

Pefloxacin Mesylate Capsules

Product Name
甲磺酸培氟沙星胶囊
Approval Number
国药准字H33022552
Approval Date
Apr 24, 2020
NMPA

Compound Paracetamol and Amantadine Hydrochloride Capsules

Product Name
复方氨酚烷胺胶囊
Approval Number
国药准字H33020485
Approval Date
Apr 2, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.